nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimexolone—NR3C1—hematologic cancer	0.0861	1	CbGaD
Rimexolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.07	0.209	CiPCiCtD
Rimexolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.07	0.209	CiPCiCtD
Rimexolone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0676	0.202	CiPCiCtD
Rimexolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0655	0.195	CiPCiCtD
Rimexolone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0618	0.185	CiPCiCtD
Rimexolone—Dexamethasone—hematologic cancer	0.0497	0.208	CrCtD
Rimexolone—Betamethasone—hematologic cancer	0.0497	0.208	CrCtD
Rimexolone—Triamcinolone—hematologic cancer	0.0485	0.203	CrCtD
Rimexolone—Prednisone—hematologic cancer	0.046	0.193	CrCtD
Rimexolone—Prednisolone—hematologic cancer	0.0449	0.188	CrCtD
Rimexolone—SERPINA6—Triamcinolone—hematologic cancer	0.0309	0.269	CbGbCtD
Rimexolone—SERPINA6—Prednisolone—hematologic cancer	0.0261	0.228	CbGbCtD
Rimexolone—NR3C1—Triamcinolone—hematologic cancer	0.0144	0.126	CbGbCtD
Rimexolone—NR3C1—Betamethasone—hematologic cancer	0.0124	0.108	CbGbCtD
Rimexolone—NR3C1—Prednisolone—hematologic cancer	0.0122	0.106	CbGbCtD
Rimexolone—NR3C1—Prednisone—hematologic cancer	0.0115	0.101	CbGbCtD
Rimexolone—NR3C1—Dexamethasone—hematologic cancer	0.0072	0.0627	CbGbCtD
Rimexolone—Ciclesonide—Prednisone—hematologic cancer	0.00164	0.0092	CrCrCtD
Rimexolone—Ciclesonide—Prednisolone—hematologic cancer	0.0016	0.00898	CrCrCtD
Rimexolone—Flurandrenolide—Betamethasone—hematologic cancer	0.00158	0.00887	CrCrCtD
Rimexolone—Flurandrenolide—Dexamethasone—hematologic cancer	0.00158	0.00887	CrCrCtD
Rimexolone—Medrysone—Prednisolone—hematologic cancer	0.00154	0.00864	CrCrCtD
Rimexolone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00153	0.00858	CrCrCtD
Rimexolone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00153	0.00858	CrCrCtD
Rimexolone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00149	0.00838	CrCrCtD
Rimexolone—Difluprednate—Betamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Difluprednate—Dexamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00148	0.0083	CrCrCtD
Rimexolone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00144	0.00811	CrCrCtD
Rimexolone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00144	0.00811	CrCrCtD
Rimexolone—Difluprednate—Triamcinolone—hematologic cancer	0.00144	0.00811	CrCrCtD
Rimexolone—Flurandrenolide—Prednisolone—hematologic cancer	0.00143	0.00803	CrCrCtD
Rimexolone—Fluocinonide—Dexamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Testolactone—Dexamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Testolactone—Betamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Beclomethasone—Betamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Beclomethasone—Dexamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Clocortolone—Dexamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Clocortolone—Betamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Fluocinonide—Betamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Prednicarbate—Betamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Prednicarbate—Dexamethasone—hematologic cancer	0.00139	0.00781	CrCrCtD
Rimexolone—Hydrocortamate—Prednisone—hematologic cancer	0.00137	0.0077	CrCrCtD
Rimexolone—Prednicarbate—Triamcinolone—hematologic cancer	0.00136	0.00763	CrCrCtD
Rimexolone—Testolactone—Triamcinolone—hematologic cancer	0.00136	0.00763	CrCrCtD
Rimexolone—Clocortolone—Triamcinolone—hematologic cancer	0.00136	0.00763	CrCrCtD
Rimexolone—Beclomethasone—Triamcinolone—hematologic cancer	0.00136	0.00763	CrCrCtD
Rimexolone—Fluocinonide—Triamcinolone—hematologic cancer	0.00136	0.00763	CrCrCtD
Rimexolone—Fluocortolone—Betamethasone—hematologic cancer	0.00135	0.00758	CrCrCtD
Rimexolone—Fluocortolone—Dexamethasone—hematologic cancer	0.00135	0.00758	CrCrCtD
Rimexolone—Hydrocortamate—Prednisolone—hematologic cancer	0.00134	0.00751	CrCrCtD
Rimexolone—Fluocortolone—Triamcinolone—hematologic cancer	0.00132	0.00741	CrCrCtD
Rimexolone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00131	0.00737	CrCrCtD
Rimexolone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00131	0.00737	CrCrCtD
Rimexolone—Alclometasone—Betamethasone—hematologic cancer	0.00131	0.00737	CrCrCtD
Rimexolone—Alclometasone—Dexamethasone—hematologic cancer	0.00131	0.00737	CrCrCtD
Rimexolone—Prednicarbate—Prednisone—hematologic cancer	0.00129	0.00724	CrCrCtD
Rimexolone—Testolactone—Prednisone—hematologic cancer	0.00129	0.00724	CrCrCtD
Rimexolone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00128	0.0072	CrCrCtD
Rimexolone—Alclometasone—Triamcinolone—hematologic cancer	0.00128	0.0072	CrCrCtD
Rimexolone—Amcinonide—Betamethasone—hematologic cancer	0.00128	0.00717	CrCrCtD
Rimexolone—Budesonide—Betamethasone—hematologic cancer	0.00128	0.00717	CrCrCtD
Rimexolone—Amcinonide—Dexamethasone—hematologic cancer	0.00128	0.00717	CrCrCtD
Rimexolone—Budesonide—Dexamethasone—hematologic cancer	0.00128	0.00717	CrCrCtD
Rimexolone—Testolactone—Prednisolone—hematologic cancer	0.00126	0.00706	CrCrCtD
Rimexolone—Beclomethasone—Prednisolone—hematologic cancer	0.00126	0.00706	CrCrCtD
Rimexolone—Clocortolone—Prednisolone—hematologic cancer	0.00126	0.00706	CrCrCtD
Rimexolone—Prednicarbate—Prednisolone—hematologic cancer	0.00126	0.00706	CrCrCtD
Rimexolone—Fluocortolone—Prednisone—hematologic cancer	0.00125	0.00703	CrCrCtD
Rimexolone—Amcinonide—Triamcinolone—hematologic cancer	0.00125	0.00701	CrCrCtD
Rimexolone—Budesonide—Triamcinolone—hematologic cancer	0.00125	0.00701	CrCrCtD
Rimexolone—Desonide—Dexamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Prednisone—Betamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Desonide—Betamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Clobetasol propionate—Betamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Prednisone—Dexamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Diflorasone—Dexamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Diflorasone—Betamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Flunisolide—Betamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Flunisolide—Dexamethasone—hematologic cancer	0.00124	0.00699	CrCrCtD
Rimexolone—Fluocortolone—Prednisolone—hematologic cancer	0.00122	0.00686	CrCrCtD
Rimexolone—Alclometasone—Prednisone—hematologic cancer	0.00122	0.00684	CrCrCtD
Rimexolone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00121	0.00683	CrCrCtD
Rimexolone—Desonide—Triamcinolone—hematologic cancer	0.00121	0.00683	CrCrCtD
Rimexolone—Prednisone—Triamcinolone—hematologic cancer	0.00121	0.00683	CrCrCtD
Rimexolone—Diflorasone—Triamcinolone—hematologic cancer	0.00121	0.00683	CrCrCtD
Rimexolone—Flunisolide—Triamcinolone—hematologic cancer	0.00121	0.00683	CrCrCtD
Rimexolone—Paramethasone—Dexamethasone—hematologic cancer	0.00121	0.00681	CrCrCtD
Rimexolone—Paramethasone—Betamethasone—hematologic cancer	0.00121	0.00681	CrCrCtD
Rimexolone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00119	0.00667	CrCrCtD
Rimexolone—Alclometasone—Prednisolone—hematologic cancer	0.00119	0.00667	CrCrCtD
Rimexolone—Paramethasone—Triamcinolone—hematologic cancer	0.00118	0.00666	CrCrCtD
Rimexolone—Budesonide—Prednisone—hematologic cancer	0.00118	0.00665	CrCrCtD
Rimexolone—Amcinonide—Prednisone—hematologic cancer	0.00118	0.00665	CrCrCtD
Rimexolone—Desoximetasone—Dexamethasone—hematologic cancer	0.00118	0.00665	CrCrCtD
Rimexolone—Desoximetasone—Betamethasone—hematologic cancer	0.00118	0.00665	CrCrCtD
Rimexolone—Desoximetasone—Triamcinolone—hematologic cancer	0.00116	0.0065	CrCrCtD
Rimexolone—Budesonide—Prednisolone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Amcinonide—Prednisolone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Loteprednol—Dexamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Fluorometholone—Dexamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Triamcinolone—Betamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Triamcinolone—Dexamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Mometasone—Betamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Mometasone—Dexamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Loteprednol—Betamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Fluorometholone—Betamethasone—hematologic cancer	0.00115	0.00649	CrCrCtD
Rimexolone—Diflorasone—Prednisone—hematologic cancer	0.00115	0.00648	CrCrCtD
Rimexolone—Flunisolide—Prednisone—hematologic cancer	0.00115	0.00648	CrCrCtD
Rimexolone—Clobetasol propionate—Prednisone—hematologic cancer	0.00115	0.00648	CrCrCtD
Rimexolone—Desonide—Prednisone—hematologic cancer	0.00115	0.00648	CrCrCtD
Rimexolone—Dexamethasone—Betamethasone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Betamethasone—Dexamethasone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Loteprednol—Triamcinolone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Fluorometholone—Triamcinolone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Mometasone—Triamcinolone—hematologic cancer	0.00113	0.00634	CrCrCtD
Rimexolone—Desonide—Prednisolone—hematologic cancer	0.00113	0.00633	CrCrCtD
Rimexolone—Prednisone—Prednisolone—hematologic cancer	0.00113	0.00633	CrCrCtD
Rimexolone—Diflorasone—Prednisolone—hematologic cancer	0.00113	0.00633	CrCrCtD
Rimexolone—Flunisolide—Prednisolone—hematologic cancer	0.00113	0.00633	CrCrCtD
Rimexolone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00113	0.00633	CrCrCtD
Rimexolone—Paramethasone—Prednisone—hematologic cancer	0.00112	0.00632	CrCrCtD
Rimexolone—Dexamethasone—Triamcinolone—hematologic cancer	0.0011	0.0062	CrCrCtD
Rimexolone—Betamethasone—Triamcinolone—hematologic cancer	0.0011	0.0062	CrCrCtD
Rimexolone—Paramethasone—Prednisolone—hematologic cancer	0.0011	0.00617	CrCrCtD
Rimexolone—Desoximetasone—Prednisone—hematologic cancer	0.0011	0.00616	CrCrCtD
Rimexolone—Methylprednisolone—Betamethasone—hematologic cancer	0.00108	0.00607	CrCrCtD
Rimexolone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00108	0.00607	CrCrCtD
Rimexolone—Fluorometholone—Prednisone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Triamcinolone—Prednisone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Mometasone—Prednisone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Loteprednol—Prednisone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Desoximetasone—Prednisolone—hematologic cancer	0.00107	0.00602	CrCrCtD
Rimexolone—Prednisolone—Betamethasone—hematologic cancer	0.00106	0.00594	CrCrCtD
Rimexolone—Prednisolone—Dexamethasone—hematologic cancer	0.00106	0.00594	CrCrCtD
Rimexolone—Methylprednisolone—Triamcinolone—hematologic cancer	0.00105	0.00593	CrCrCtD
Rimexolone—Dexamethasone—Prednisone—hematologic cancer	0.00105	0.00588	CrCrCtD
Rimexolone—Betamethasone—Prednisone—hematologic cancer	0.00105	0.00588	CrCrCtD
Rimexolone—Triamcinolone—Prednisolone—hematologic cancer	0.00104	0.00587	CrCrCtD
Rimexolone—Loteprednol—Prednisolone—hematologic cancer	0.00104	0.00587	CrCrCtD
Rimexolone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00104	0.00587	CrCrCtD
Rimexolone—Mometasone—Prednisolone—hematologic cancer	0.00104	0.00587	CrCrCtD
Rimexolone—Fluorometholone—Prednisolone—hematologic cancer	0.00104	0.00587	CrCrCtD
Rimexolone—Prednisolone—Triamcinolone—hematologic cancer	0.00103	0.0058	CrCrCtD
Rimexolone—Dexamethasone—Prednisolone—hematologic cancer	0.00102	0.00574	CrCrCtD
Rimexolone—Betamethasone—Prednisolone—hematologic cancer	0.00102	0.00574	CrCrCtD
Rimexolone—Hydrocortisone—Betamethasone—hematologic cancer	0.00101	0.0057	CrCrCtD
Rimexolone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00101	0.0057	CrCrCtD
Rimexolone—Methylprednisolone—Prednisone—hematologic cancer	0.001	0.00563	CrCrCtD
Rimexolone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00099	0.00557	CrCrCtD
Rimexolone—Prednisolone—Prednisone—hematologic cancer	0.000979	0.00551	CrCrCtD
Rimexolone—Methylprednisolone—Prednisolone—hematologic cancer	0.000977	0.00549	CrCrCtD
Rimexolone—Hydrocortisone—Prednisone—hematologic cancer	0.00094	0.00528	CrCrCtD
Rimexolone—Hydrocortisone—Prednisolone—hematologic cancer	0.000918	0.00516	CrCrCtD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000484	0.0406	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.000242	0.0203	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.000242	0.0203	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.000242	0.0203	CbGpPWpGaD
Rimexolone—SERPINA6—hematopoietic system—hematologic cancer	0.000241	0.204	CbGeAlD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.00021	0.0176	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.00021	0.0176	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000201	0.0169	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000186	0.0156	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000183	0.0153	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000179	0.015	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000176	0.0147	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000176	0.0147	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000176	0.0147	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000169	0.0141	CbGpPWpGaD
Rimexolone—SERPINA6—blood—hematologic cancer	0.00016	0.135	CbGeAlD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.00016	0.0134	CbGpPWpGaD
Rimexolone—SERPINA6—bone marrow—hematologic cancer	0.000155	0.131	CbGeAlD
Rimexolone—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.000146	0.0122	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000142	0.0119	CbGpPWpGaD
Rimexolone—SERPINA6—lung—hematologic cancer	0.00014	0.119	CbGeAlD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000137	0.0115	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000133	0.0112	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.000132	0.0111	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000132	0.011	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.00013	0.0109	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000129	0.0108	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000129	0.0108	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000123	0.0103	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000121	0.0101	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000121	0.0101	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000119	0.00994	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000115	0.00968	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000115	0.00968	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000115	0.00964	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000114	0.00955	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000114	0.00954	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000113	0.00943	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000112	0.00938	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.00011	0.0092	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000107	0.009	CbGpPWpGaD
Rimexolone—NR3C1—hematopoietic system—hematologic cancer	0.000106	0.0895	CbGeAlD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000104	0.00872	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	9.85e-05	0.00825	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	9.61e-05	0.00806	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—ARNTL—hematologic cancer	9.5e-05	0.00796	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—EBF1—hematologic cancer	8.84e-05	0.00741	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	8.67e-05	0.00727	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	8.61e-05	0.00721	CbGpPWpGaD
Rimexolone—Rhinitis—Bexarotene—hematologic cancer	8.54e-05	0.00257	CcSEcCtD
Rimexolone—Pharyngitis—Bexarotene—hematologic cancer	8.45e-05	0.00254	CcSEcCtD
Rimexolone—Vision blurred—Anagrelide—hematologic cancer	8.45e-05	0.00254	CcSEcCtD
Rimexolone—Pharyngitis—Fludarabine—hematologic cancer	8.43e-05	0.00254	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	8.22e-05	0.00689	CbGpPWpGaD
Rimexolone—Headache—Ruxolitinib—hematologic cancer	8.03e-05	0.00242	CcSEcCtD
Rimexolone—NR3C1—gonad—hematologic cancer	8.03e-05	0.068	CbGeAlD
Rimexolone—Lacrimation—Epirubicin—hematologic cancer	7.98e-05	0.0024	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	7.97e-05	0.00668	CbGpPWpGaD
Rimexolone—Discomfort—Methoxsalen—hematologic cancer	7.91e-05	0.00238	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	7.9e-05	0.00662	CbGpPWpGaD
Rimexolone—Rhinitis—Nilotinib—hematologic cancer	7.89e-05	0.00237	CcSEcCtD
Rimexolone—Oedema—Nelarabine—hematologic cancer	7.85e-05	0.00236	CcSEcCtD
Rimexolone—Rhinitis—Imatinib—hematologic cancer	7.84e-05	0.00236	CcSEcCtD
Rimexolone—Pharyngitis—Nilotinib—hematologic cancer	7.81e-05	0.00235	CcSEcCtD
Rimexolone—Pharyngitis—Imatinib—hematologic cancer	7.76e-05	0.00234	CcSEcCtD
Rimexolone—Oedema—Methoxsalen—hematologic cancer	7.67e-05	0.00231	CcSEcCtD
Rimexolone—Pruritus—Vorinostat—hematologic cancer	7.67e-05	0.00231	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	7.64e-05	0.0064	CbGpPWpGaD
Rimexolone—Pharyngitis—Cladribine—hematologic cancer	7.63e-05	0.0023	CcSEcCtD
Rimexolone—Discomfort—Daunorubicin—hematologic cancer	7.57e-05	0.00228	CcSEcCtD
Rimexolone—Discomfort—Anagrelide—hematologic cancer	7.54e-05	0.00227	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—ID3—hematologic cancer	7.52e-05	0.0063	CbGpPWpGaD
Rimexolone—Herpes simplex—Betamethasone—hematologic cancer	7.47e-05	0.00225	CcSEcCtD
Rimexolone—Herpes simplex—Dexamethasone—hematologic cancer	7.47e-05	0.00225	CcSEcCtD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	7.46e-05	0.00626	CbGpPWpGaD
Rimexolone—Oedema—Mercaptopurine—hematologic cancer	7.45e-05	0.00224	CcSEcCtD
Rimexolone—Lacrimation—Doxorubicin—hematologic cancer	7.38e-05	0.00222	CcSEcCtD
Rimexolone—Oedema—Daunorubicin—hematologic cancer	7.35e-05	0.00221	CcSEcCtD
Rimexolone—Oedema—Clofarabine—hematologic cancer	7.35e-05	0.00221	CcSEcCtD
Rimexolone—Hypotension—Nelarabine—hematologic cancer	7.34e-05	0.00221	CcSEcCtD
Rimexolone—Oedema—Anagrelide—hematologic cancer	7.32e-05	0.0022	CcSEcCtD
Rimexolone—Pharyngitis—Vinblastine—hematologic cancer	7.32e-05	0.0022	CcSEcCtD
Rimexolone—Dysgeusia—Bexarotene—hematologic cancer	7.26e-05	0.00218	CcSEcCtD
Rimexolone—Dysgeusia—Dasatinib—hematologic cancer	7.26e-05	0.00218	CcSEcCtD
Rimexolone—Keratitis—Epirubicin—hematologic cancer	7.23e-05	0.00218	CcSEcCtD
Rimexolone—Hypotension—Methoxsalen—hematologic cancer	7.17e-05	0.00216	CcSEcCtD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	7.02e-05	0.00588	CbGpPWpGaD
Rimexolone—NR3C1—blood—hematologic cancer	7e-05	0.0593	CbGeAlD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	7e-05	0.00587	CbGpPWpGaD
Rimexolone—Vision blurred—Dasatinib—hematologic cancer	6.99e-05	0.0021	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—GATA2—hematologic cancer	6.94e-05	0.00581	CbGpPWpGaD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	6.93e-05	0.00581	CbGpPWpGaD
Rimexolone—Hypotension—Clofarabine—hematologic cancer	6.87e-05	0.00207	CcSEcCtD
Rimexolone—Oedema—Teniposide—hematologic cancer	6.86e-05	0.00207	CcSEcCtD
Rimexolone—Hypotension—Anagrelide—hematologic cancer	6.84e-05	0.00206	CcSEcCtD
Rimexolone—Hypotension—Pentostatin—hematologic cancer	6.84e-05	0.00206	CcSEcCtD
Rimexolone—Rhinitis—Lenalidomide—hematologic cancer	6.83e-05	0.00206	CcSEcCtD
Rimexolone—Headache—Vorinostat—hematologic cancer	6.79e-05	0.00204	CcSEcCtD
Rimexolone—NR3C1—bone marrow—hematologic cancer	6.77e-05	0.0574	CbGeAlD
Rimexolone—Pharyngitis—Lenalidomide—hematologic cancer	6.77e-05	0.00204	CcSEcCtD
Rimexolone—Dysgeusia—Nilotinib—hematologic cancer	6.71e-05	0.00202	CcSEcCtD
Rimexolone—Keratitis—Doxorubicin—hematologic cancer	6.69e-05	0.00201	CcSEcCtD
Rimexolone—Dysgeusia—Imatinib—hematologic cancer	6.67e-05	0.00201	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	6.66e-05	0.00558	CbGpPWpGaD
Rimexolone—Pruritus—Mechlorethamine—hematologic cancer	6.59e-05	0.00198	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	6.54e-05	0.00548	CbGpPWpGaD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	6.53e-05	0.00547	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—AR—hematologic cancer	6.53e-05	0.00547	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	6.5e-05	0.00545	CbGpPWpGaD
Rimexolone—Vision blurred—Nilotinib—hematologic cancer	6.45e-05	0.00194	CcSEcCtD
Rimexolone—Vision blurred—Imatinib—hematologic cancer	6.42e-05	0.00193	CcSEcCtD
Rimexolone—Hypotension—Teniposide—hematologic cancer	6.41e-05	0.00193	CcSEcCtD
Rimexolone—Oedema—Busulfan—hematologic cancer	6.36e-05	0.00191	CcSEcCtD
Rimexolone—Dry eye—Dexamethasone—hematologic cancer	6.36e-05	0.00191	CcSEcCtD
Rimexolone—Dry eye—Betamethasone—hematologic cancer	6.36e-05	0.00191	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	6.31e-05	0.00529	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	6.3e-05	0.00528	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	6.24e-05	0.00523	CbGpPWpGaD
Rimexolone—Discomfort—Dasatinib—hematologic cancer	6.23e-05	0.00188	CcSEcCtD
Rimexolone—Discomfort—Bexarotene—hematologic cancer	6.23e-05	0.00188	CcSEcCtD
Rimexolone—Discomfort—Fludarabine—hematologic cancer	6.22e-05	0.00187	CcSEcCtD
Rimexolone—Oedema—Procarbazine—hematologic cancer	6.17e-05	0.00186	CcSEcCtD
Rimexolone—NR3C1—lung—hematologic cancer	6.14e-05	0.052	CbGeAlD
Rimexolone—Oedema—Dasatinib—hematologic cancer	6.05e-05	0.00182	CcSEcCtD
Rimexolone—Oedema—Bexarotene—hematologic cancer	6.05e-05	0.00182	CcSEcCtD
Rimexolone—Oedema—Fludarabine—hematologic cancer	6.03e-05	0.00182	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	6e-05	0.00503	CbGpPWpGaD
Rimexolone—Hypotension—Busulfan—hematologic cancer	5.94e-05	0.00179	CcSEcCtD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	5.83e-05	0.00488	CbGpPWpGaD
Rimexolone—Dysgeusia—Lenalidomide—hematologic cancer	5.81e-05	0.00175	CcSEcCtD
Rimexolone—NR3C1—testis—hematologic cancer	5.79e-05	0.049	CbGeAlD
Rimexolone—Hypotension—Procarbazine—hematologic cancer	5.77e-05	0.00174	CcSEcCtD
Rimexolone—Discomfort—Nilotinib—hematologic cancer	5.76e-05	0.00173	CcSEcCtD
Rimexolone—Discomfort—Imatinib—hematologic cancer	5.73e-05	0.00172	CcSEcCtD
Rimexolone—Rhinitis—Thalidomide—hematologic cancer	5.67e-05	0.00171	CcSEcCtD
Rimexolone—Hypotension—Dasatinib—hematologic cancer	5.65e-05	0.0017	CcSEcCtD
Rimexolone—Discomfort—Cladribine—hematologic cancer	5.63e-05	0.00169	CcSEcCtD
Rimexolone—Pharyngitis—Thalidomide—hematologic cancer	5.62e-05	0.00169	CcSEcCtD
Rimexolone—Vision blurred—Lenalidomide—hematologic cancer	5.59e-05	0.00168	CcSEcCtD
Rimexolone—Oedema—Nilotinib—hematologic cancer	5.59e-05	0.00168	CcSEcCtD
Rimexolone—Oedema—Imatinib—hematologic cancer	5.56e-05	0.00167	CcSEcCtD
Rimexolone—Eye pain—Dexamethasone—hematologic cancer	5.54e-05	0.00167	CcSEcCtD
Rimexolone—Eye pain—Betamethasone—hematologic cancer	5.54e-05	0.00167	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	5.49e-05	0.00461	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—RARA—hematologic cancer	5.46e-05	0.00458	CbGpPWpGaD
Rimexolone—Oedema—Cladribine—hematologic cancer	5.46e-05	0.00164	CcSEcCtD
Rimexolone—Herpes simplex—Methotrexate—hematologic cancer	5.44e-05	0.00164	CcSEcCtD
Rimexolone—Pruritus—Methoxsalen—hematologic cancer	5.43e-05	0.00163	CcSEcCtD
Rimexolone—Discomfort—Vinblastine—hematologic cancer	5.4e-05	0.00162	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	5.39e-05	0.00452	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	5.36e-05	0.00449	CbGpPWpGaD
Rimexolone—Dysgeusia—Bortezomib—hematologic cancer	5.35e-05	0.00161	CcSEcCtD
Rimexolone—Pharyngitis—Alitretinoin—hematologic cancer	5.34e-05	0.00161	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	5.3e-05	0.00444	CbGpPWpGaD
Rimexolone—Hypotension—Nilotinib—hematologic cancer	5.22e-05	0.00157	CcSEcCtD
Rimexolone—Pruritus—Clofarabine—hematologic cancer	5.2e-05	0.00156	CcSEcCtD
Rimexolone—Pruritus—Daunorubicin—hematologic cancer	5.2e-05	0.00156	CcSEcCtD
Rimexolone—Hypotension—Imatinib—hematologic cancer	5.19e-05	0.00156	CcSEcCtD
Rimexolone—Pruritus—Pentostatin—hematologic cancer	5.18e-05	0.00156	CcSEcCtD
Rimexolone—Pruritus—Anagrelide—hematologic cancer	5.18e-05	0.00156	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	5.16e-05	0.00432	CbGpPWpGaD
Rimexolone—Vision blurred—Bortezomib—hematologic cancer	5.15e-05	0.00155	CcSEcCtD
Rimexolone—Hypotension—Cladribine—hematologic cancer	5.1e-05	0.00154	CcSEcCtD
Rimexolone—Herpes simplex—Epirubicin—hematologic cancer	5.09e-05	0.00153	CcSEcCtD
Rimexolone—Lacrimation increased—Epirubicin—hematologic cancer	5.09e-05	0.00153	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—CEBPD—hematologic cancer	5.08e-05	0.00426	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—CEBPA—hematologic cancer	5.08e-05	0.00426	CbGpPWpGaD
Rimexolone—Rhinitis—Mitoxantrone—hematologic cancer	5.06e-05	0.00152	CcSEcCtD
Rimexolone—Rhinitis—Irinotecan—hematologic cancer	5.06e-05	0.00152	CcSEcCtD
Rimexolone—Pharyngitis—Mitoxantrone—hematologic cancer	5.01e-05	0.00151	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	5.01e-05	0.0042	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	5e-05	0.00419	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	5e-05	0.00419	CbGpPWpGaD
Rimexolone—Discomfort—Lenalidomide—hematologic cancer	4.99e-05	0.0015	CcSEcCtD
Rimexolone—Oedema—Melphalan—hematologic cancer	4.98e-05	0.0015	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	4.96e-05	0.00416	CbGpPWpGaD
Rimexolone—Rhinitis—Gemcitabine—hematologic cancer	4.93e-05	0.00148	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	4.93e-05	0.00413	CbGpPWpGaD
Rimexolone—Discomfort—Hydroxyurea—hematologic cancer	4.92e-05	0.00148	CcSEcCtD
Rimexolone—Headache—Nelarabine—hematologic cancer	4.92e-05	0.00148	CcSEcCtD
Rimexolone—Pharyngitis—Gemcitabine—hematologic cancer	4.88e-05	0.00147	CcSEcCtD
Rimexolone—Pruritus—Teniposide—hematologic cancer	4.86e-05	0.00146	CcSEcCtD
Rimexolone—Oedema—Lenalidomide—hematologic cancer	4.84e-05	0.00146	CcSEcCtD
Rimexolone—Dysgeusia—Thalidomide—hematologic cancer	4.82e-05	0.00145	CcSEcCtD
Rimexolone—Difluprednate—NR3C1—hematologic cancer	4.82e-05	0.0436	CrCbGaD
Rimexolone—Headache—Methoxsalen—hematologic cancer	4.81e-05	0.00145	CcSEcCtD
Rimexolone—Vision blurred—Thiotepa—hematologic cancer	4.8e-05	0.00144	CcSEcCtD
Rimexolone—Oedema—Hydroxyurea—hematologic cancer	4.78e-05	0.00144	CcSEcCtD
Rimexolone—Herpes simplex—Doxorubicin—hematologic cancer	4.71e-05	0.00142	CcSEcCtD
Rimexolone—Lacrimation increased—Doxorubicin—hematologic cancer	4.71e-05	0.00142	CcSEcCtD
Rimexolone—Clocortolone—NR3C1—hematologic cancer	4.67e-05	0.0423	CrCbGaD
Rimexolone—Prednicarbate—NR3C1—hematologic cancer	4.67e-05	0.0423	CrCbGaD
Rimexolone—Hypotension—Melphalan—hematologic cancer	4.65e-05	0.0014	CcSEcCtD
Rimexolone—Vision blurred—Thalidomide—hematologic cancer	4.64e-05	0.0014	CcSEcCtD
Rimexolone—Headache—Daunorubicin—hematologic cancer	4.6e-05	0.00139	CcSEcCtD
Rimexolone—Headache—Clofarabine—hematologic cancer	4.6e-05	0.00139	CcSEcCtD
Rimexolone—Discomfort—Bortezomib—hematologic cancer	4.59e-05	0.00138	CcSEcCtD
Rimexolone—Headache—Pentostatin—hematologic cancer	4.58e-05	0.00138	CcSEcCtD
Rimexolone—Headache—Anagrelide—hematologic cancer	4.58e-05	0.00138	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NCOR2—hematologic cancer	4.58e-05	0.00384	CbGpPWpGaD
Rimexolone—Discomfort—Bleomycin—hematologic cancer	4.56e-05	0.00137	CcSEcCtD
Rimexolone—Hypotension—Lenalidomide—hematologic cancer	4.53e-05	0.00136	CcSEcCtD
Rimexolone—Pruritus—Busulfan—hematologic cancer	4.5e-05	0.00135	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	4.49e-05	0.00376	CbGpPWpGaD
Rimexolone—Discomfort—Vinorelbine—hematologic cancer	4.49e-05	0.00135	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	4.48e-05	0.00376	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	4.48e-05	0.00376	CbGpPWpGaD
Rimexolone—Vision blurred—Carmustine—hematologic cancer	4.46e-05	0.00134	CcSEcCtD
Rimexolone—Oedema—Bortezomib—hematologic cancer	4.46e-05	0.00134	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	4.45e-05	0.00373	CbGpPWpGaD
Rimexolone—Oedema—Bleomycin—hematologic cancer	4.42e-05	0.00133	CcSEcCtD
Rimexolone—Desonide—NR3C1—hematologic cancer	4.42e-05	0.04	CrCbGaD
Rimexolone—Diflorasone—NR3C1—hematologic cancer	4.42e-05	0.04	CrCbGaD
Rimexolone—Headache—Idarubicin—hematologic cancer	4.42e-05	0.00133	CcSEcCtD
Rimexolone—Vision blurred—Alitretinoin—hematologic cancer	4.42e-05	0.00133	CcSEcCtD
Rimexolone—Pruritus—Procarbazine—hematologic cancer	4.37e-05	0.00131	CcSEcCtD
Rimexolone—Vision blurred—Ifosfamide—hematologic cancer	4.37e-05	0.00131	CcSEcCtD
Rimexolone—Dry eye—Epirubicin—hematologic cancer	4.33e-05	0.0013	CcSEcCtD
Rimexolone—Desoximetasone—NR3C1—hematologic cancer	4.31e-05	0.039	CrCbGaD
Rimexolone—Dysgeusia—Mitoxantrone—hematologic cancer	4.31e-05	0.0013	CcSEcCtD
Rimexolone—Headache—Teniposide—hematologic cancer	4.3e-05	0.00129	CcSEcCtD
Rimexolone—Pruritus—Bexarotene—hematologic cancer	4.28e-05	0.00129	CcSEcCtD
Rimexolone—Pruritus—Dasatinib—hematologic cancer	4.28e-05	0.00129	CcSEcCtD
Rimexolone—Pruritus—Fludarabine—hematologic cancer	4.27e-05	0.00128	CcSEcCtD
Rimexolone—Loteprednol—NR3C1—hematologic cancer	4.26e-05	0.0386	CrCbGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	4.26e-05	0.00357	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	4.25e-05	0.00356	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—NCOR1—hematologic cancer	4.24e-05	0.00356	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	4.24e-05	0.00355	CbGpPWpGaD
Rimexolone—NR3C1—lymph node—hematologic cancer	4.2e-05	0.0355	CbGeAlD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	4.17e-05	0.0035	CbGpPWpGaD
Rimexolone—Hypotension—Bortezomib—hematologic cancer	4.16e-05	0.00125	CcSEcCtD
Rimexolone—Vision blurred—Mitoxantrone—hematologic cancer	4.14e-05	0.00125	CcSEcCtD
Rimexolone—Discomfort—Thalidomide—hematologic cancer	4.14e-05	0.00125	CcSEcCtD
Rimexolone—Hypotension—Bleomycin—hematologic cancer	4.13e-05	0.00124	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	4.11e-05	0.00344	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	4.07e-05	0.00341	CbGpPWpGaD
Rimexolone—Hypotension—Vinorelbine—hematologic cancer	4.07e-05	0.00122	CcSEcCtD
Rimexolone—Pruritus—Chlorambucil—hematologic cancer	4.04e-05	0.00122	CcSEcCtD
Rimexolone—Oedema—Thalidomide—hematologic cancer	4.02e-05	0.00121	CcSEcCtD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	4.01e-05	0.00336	CbGpPWpGaD
Rimexolone—Dry eye—Doxorubicin—hematologic cancer	4.01e-05	0.00121	CcSEcCtD
Rimexolone—Headache—Busulfan—hematologic cancer	3.98e-05	0.0012	CcSEcCtD
Rimexolone—Pruritus—Nilotinib—hematologic cancer	3.95e-05	0.00119	CcSEcCtD
Rimexolone—Discomfort—Alitretinoin—hematologic cancer	3.94e-05	0.00119	CcSEcCtD
Rimexolone—Pruritus—Imatinib—hematologic cancer	3.93e-05	0.00118	CcSEcCtD
Rimexolone—Medrysone—NR3C1—hematologic cancer	3.92e-05	0.0354	CrCbGaD
Rimexolone—Discomfort—Ifosfamide—hematologic cancer	3.9e-05	0.00117	CcSEcCtD
Rimexolone—Headache—Procarbazine—hematologic cancer	3.87e-05	0.00116	CcSEcCtD
Rimexolone—Pruritus—Cladribine—hematologic cancer	3.86e-05	0.00116	CcSEcCtD
Rimexolone—Oedema—Carmustine—hematologic cancer	3.86e-05	0.00116	CcSEcCtD
Rimexolone—Oedema—Alitretinoin—hematologic cancer	3.82e-05	0.00115	CcSEcCtD
Rimexolone—Rhinitis—Triamcinolone—hematologic cancer	3.82e-05	0.00115	CcSEcCtD
Rimexolone—Headache—Dasatinib—hematologic cancer	3.79e-05	0.00114	CcSEcCtD
Rimexolone—Headache—Bexarotene—hematologic cancer	3.79e-05	0.00114	CcSEcCtD
Rimexolone—Pharyngitis—Triamcinolone—hematologic cancer	3.78e-05	0.00114	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	3.78e-05	0.00317	CbGpPWpGaD
Rimexolone—Oedema—Ifosfamide—hematologic cancer	3.78e-05	0.00114	CcSEcCtD
Rimexolone—Headache—Fludarabine—hematologic cancer	3.78e-05	0.00114	CcSEcCtD
Rimexolone—Flurandrenolide—NR3C1—hematologic cancer	3.78e-05	0.0342	CrCbGaD
Rimexolone—Eye pain—Epirubicin—hematologic cancer	3.77e-05	0.00114	CcSEcCtD
Rimexolone—Vision blurred—Cisplatin—hematologic cancer	3.76e-05	0.00113	CcSEcCtD
Rimexolone—Hypotension—Thalidomide—hematologic cancer	3.76e-05	0.00113	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	3.73e-05	0.00313	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—STAT5B—hematologic cancer	3.73e-05	0.00312	CbGpPWpGaD
Rimexolone—Flumethasone Pivalate—NR3C1—hematologic cancer	3.71e-05	0.0336	CrCbGaD
Rimexolone—Discomfort—Mitoxantrone—hematologic cancer	3.7e-05	0.00111	CcSEcCtD
Rimexolone—Discomfort—Irinotecan—hematologic cancer	3.7e-05	0.00111	CcSEcCtD
Rimexolone—Oedema—Vincristine—hematologic cancer	3.69e-05	0.00111	CcSEcCtD
Rimexolone—Halobetasol Propionate—NR3C1—hematologic cancer	3.65e-05	0.033	CrCbGaD
Rimexolone—Hydrocortamate—NR3C1—hematologic cancer	3.65e-05	0.033	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	3.65e-05	0.00306	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	3.61e-05	0.00303	CbGpPWpGaD
Rimexolone—Hypotension—Carmustine—hematologic cancer	3.61e-05	0.00109	CcSEcCtD
Rimexolone—Discomfort—Gemcitabine—hematologic cancer	3.6e-05	0.00108	CcSEcCtD
Rimexolone—Oedema—Irinotecan—hematologic cancer	3.59e-05	0.00108	CcSEcCtD
Rimexolone—Oedema—Mitoxantrone—hematologic cancer	3.59e-05	0.00108	CcSEcCtD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	3.59e-05	0.00301	CbGpPWpGaD
Rimexolone—Dysgeusia—Etoposide—hematologic cancer	3.58e-05	0.00108	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	3.58e-05	0.003	CbGpPWpGaD
Rimexolone—Hypotension—Alitretinoin—hematologic cancer	3.57e-05	0.00108	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	3.56e-05	0.00299	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	3.54e-05	0.00297	CbGpPWpGaD
Rimexolone—Hypotension—Ifosfamide—hematologic cancer	3.53e-05	0.00106	CcSEcCtD
Rimexolone—Pruritus—Melphalan—hematologic cancer	3.52e-05	0.00106	CcSEcCtD
Rimexolone—Headache—Nilotinib—hematologic cancer	3.5e-05	0.00105	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	3.5e-05	0.00293	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	3.5e-05	0.00293	CbGpPWpGaD
Rimexolone—Oedema—Gemcitabine—hematologic cancer	3.5e-05	0.00105	CcSEcCtD
Rimexolone—Eye pain—Doxorubicin—hematologic cancer	3.49e-05	0.00105	CcSEcCtD
Rimexolone—Headache—Imatinib—hematologic cancer	3.48e-05	0.00105	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	3.46e-05	0.0029	CbGpPWpGaD
Rimexolone—Hypotension—Vincristine—hematologic cancer	3.44e-05	0.00104	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	3.44e-05	0.00289	CbGpPWpGaD
Rimexolone—Pruritus—Lenalidomide—hematologic cancer	3.43e-05	0.00103	CcSEcCtD
Rimexolone—Headache—Cladribine—hematologic cancer	3.42e-05	0.00103	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	3.4e-05	0.00285	CbGpPWpGaD
Rimexolone—Vision blurred—Prednisolone—hematologic cancer	3.4e-05	0.00102	CcSEcCtD
Rimexolone—Budesonide—NR3C1—hematologic cancer	3.39e-05	0.0307	CrCbGaD
Rimexolone—Amcinonide—NR3C1—hematologic cancer	3.39e-05	0.0307	CrCbGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	3.36e-05	0.00282	CbGpPWpGaD
Rimexolone—Discomfort—Cisplatin—hematologic cancer	3.36e-05	0.00101	CcSEcCtD
Rimexolone—Hypotension—Irinotecan—hematologic cancer	3.35e-05	0.00101	CcSEcCtD
Rimexolone—Hypotension—Mitoxantrone—hematologic cancer	3.35e-05	0.00101	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	3.28e-05	0.00275	CbGpPWpGaD
Rimexolone—Headache—Vinblastine—hematologic cancer	3.28e-05	0.000987	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	3.28e-05	0.00275	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	3.27e-05	0.00274	CbGpPWpGaD
Rimexolone—Hypotension—Gemcitabine—hematologic cancer	3.27e-05	0.000983	CcSEcCtD
Rimexolone—Oedema—Cisplatin—hematologic cancer	3.26e-05	0.000981	CcSEcCtD
Rimexolone—Dysgeusia—Triamcinolone—hematologic cancer	3.25e-05	0.000978	CcSEcCtD
Rimexolone—Mometasone—NR3C1—hematologic cancer	3.23e-05	0.0292	CrCbGaD
Rimexolone—Pruritus—Bortezomib—hematologic cancer	3.15e-05	0.000949	CcSEcCtD
Rimexolone—Pruritus—Bleomycin—hematologic cancer	3.13e-05	0.000942	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	3.11e-05	0.00261	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	3.11e-05	0.00261	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	3.08e-05	0.00258	CbGpPWpGaD
Rimexolone—Pruritus—Vinorelbine—hematologic cancer	3.08e-05	0.000927	CcSEcCtD
Rimexolone—Discomfort—Etoposide—hematologic cancer	3.08e-05	0.000926	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—GATA3—hematologic cancer	3.08e-05	0.00258	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	3.05e-05	0.00256	CbGpPWpGaD
Rimexolone—Hypotension—Cisplatin—hematologic cancer	3.05e-05	0.000916	CcSEcCtD
Rimexolone—Discomfort—Prednisolone—hematologic cancer	3.03e-05	0.000913	CcSEcCtD
Rimexolone—Headache—Lenalidomide—hematologic cancer	3.03e-05	0.000913	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	3.03e-05	0.00254	CbGpPWpGaD
Rimexolone—Beclomethasone—NR3C1—hematologic cancer	3.01e-05	0.0272	CrCbGaD
Rimexolone—Fluocinonide—NR3C1—hematologic cancer	3.01e-05	0.0272	CrCbGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	3.01e-05	0.00252	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	3e-05	0.00252	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—CREB1—hematologic cancer	3e-05	0.00251	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	3e-05	0.00251	CbGpPWpGaD
Rimexolone—Headache—Hydroxyurea—hematologic cancer	2.99e-05	0.0009	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	2.95e-05	0.00247	CbGpPWpGaD
Rimexolone—Oedema—Prednisolone—hematologic cancer	2.94e-05	0.000886	CcSEcCtD
Rimexolone—Pruritus—Thiotepa—hematologic cancer	2.94e-05	0.000885	CcSEcCtD
Rimexolone—Fluocinolone Acetonide—NR3C1—hematologic cancer	2.93e-05	0.0265	CrCbGaD
Rimexolone—Alclometasone—NR3C1—hematologic cancer	2.93e-05	0.0265	CrCbGaD
Rimexolone—NR3C1—Circadian Clock—CREBBP—hematologic cancer	2.92e-05	0.00245	CbGpPWpGaD
Rimexolone—Flunisolide—NR3C1—hematologic cancer	2.85e-05	0.0258	CrCbGaD
Rimexolone—Clobetasol propionate—NR3C1—hematologic cancer	2.85e-05	0.0258	CrCbGaD
Rimexolone—Pruritus—Thalidomide—hematologic cancer	2.84e-05	0.000856	CcSEcCtD
Rimexolone—Paramethasone—NR3C1—hematologic cancer	2.81e-05	0.0255	CrCbGaD
Rimexolone—Headache—Bortezomib—hematologic cancer	2.79e-05	0.00084	CcSEcCtD
Rimexolone—Discomfort—Triamcinolone—hematologic cancer	2.79e-05	0.00084	CcSEcCtD
Rimexolone—Hypotension—Etoposide—hematologic cancer	2.79e-05	0.00084	CcSEcCtD
Rimexolone—Ciclesonide—NR3C1—hematologic cancer	2.77e-05	0.025	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	2.75e-05	0.0023	CbGpPWpGaD
Rimexolone—Fluorometholone—NR3C1—hematologic cancer	2.75e-05	0.0248	CrCbGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	2.73e-05	0.00229	CbGpPWpGaD
Rimexolone—Headache—Vinorelbine—hematologic cancer	2.73e-05	0.000821	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	2.72e-05	0.00228	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	2.71e-05	0.00227	CbGpPWpGaD
Rimexolone—Oedema—Triamcinolone—hematologic cancer	2.71e-05	0.000815	CcSEcCtD
Rimexolone—Pruritus—Alitretinoin—hematologic cancer	2.71e-05	0.000814	CcSEcCtD
Rimexolone—Pruritus—Ifosfamide—hematologic cancer	2.67e-05	0.000805	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	2.66e-05	0.00223	CbGpPWpGaD
Rimexolone—Methylprednisolone—NR3C1—hematologic cancer	2.65e-05	0.024	CrCbGaD
Rimexolone—Headache—Thiotepa—hematologic cancer	2.6e-05	0.000784	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	2.6e-05	0.00218	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	2.56e-05	0.00214	CbGpPWpGaD
Rimexolone—Discomfort—Dexamethasone—hematologic cancer	2.53e-05	0.000762	CcSEcCtD
Rimexolone—Discomfort—Betamethasone—hematologic cancer	2.53e-05	0.000762	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—STAT1—hematologic cancer	2.52e-05	0.00211	CbGpPWpGaD
Rimexolone—Headache—Thalidomide—hematologic cancer	2.52e-05	0.000758	CcSEcCtD
Rimexolone—Pharyngitis—Methotrexate—hematologic cancer	2.5e-05	0.000752	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	2.48e-05	0.00208	CbGpPWpGaD
Rimexolone—Pruritus—Gemcitabine—hematologic cancer	2.47e-05	0.000744	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	2.47e-05	0.00207	CbGpPWpGaD
Rimexolone—Vision blurred—Prednisone—hematologic cancer	2.47e-05	0.000744	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	2.47e-05	0.00207	CbGpPWpGaD
Rimexolone—Oedema—Betamethasone—hematologic cancer	2.46e-05	0.000739	CcSEcCtD
Rimexolone—Oedema—Dexamethasone—hematologic cancer	2.46e-05	0.000739	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	2.46e-05	0.00206	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	2.45e-05	0.00205	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	2.42e-05	0.00203	CbGpPWpGaD
Rimexolone—Headache—Carmustine—hematologic cancer	2.42e-05	0.000728	CcSEcCtD
Rimexolone—NR3C1—Gene Expression—ZNF552—hematologic cancer	2.41e-05	0.00202	CbGpPWpGaD
Rimexolone—Headache—Alitretinoin—hematologic cancer	2.4e-05	0.000721	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	2.38e-05	0.002	CbGpPWpGaD
Rimexolone—Rhinitis—Epirubicin—hematologic cancer	2.36e-05	0.000711	CcSEcCtD
Rimexolone—Pharyngitis—Epirubicin—hematologic cancer	2.34e-05	0.000704	CcSEcCtD
Rimexolone—Headache—Vincristine—hematologic cancer	2.31e-05	0.000695	CcSEcCtD
Rimexolone—Hypotension—Dexamethasone—hematologic cancer	2.3e-05	0.000691	CcSEcCtD
Rimexolone—Hypotension—Betamethasone—hematologic cancer	2.3e-05	0.000691	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—STAT5A—hematologic cancer	2.27e-05	0.0019	CbGpPWpGaD
Rimexolone—Headache—Irinotecan—hematologic cancer	2.25e-05	0.000677	CcSEcCtD
Rimexolone—Headache—Mitoxantrone—hematologic cancer	2.25e-05	0.000677	CcSEcCtD
Rimexolone—Triamcinolone—NR3C1—hematologic cancer	2.24e-05	0.0203	CrCbGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	2.22e-05	0.00186	CbGpPWpGaD
Rimexolone—Discomfort—Prednisone—hematologic cancer	2.21e-05	0.000664	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	2.2e-05	0.00185	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	2.2e-05	0.00184	CbGpPWpGaD
Rimexolone—Headache—Gemcitabine—hematologic cancer	2.19e-05	0.000659	CcSEcCtD
Rimexolone—Rhinitis—Doxorubicin—hematologic cancer	2.19e-05	0.000658	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	2.18e-05	0.00183	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	2.18e-05	0.00183	CbGpPWpGaD
Rimexolone—Pharyngitis—Doxorubicin—hematologic cancer	2.16e-05	0.000651	CcSEcCtD
Rimexolone—Dysgeusia—Methotrexate—hematologic cancer	2.15e-05	0.000646	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.14e-05	0.0018	CbGpPWpGaD
Rimexolone—Oedema—Prednisone—hematologic cancer	2.14e-05	0.000644	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.13e-05	0.00179	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.12e-05	0.00178	CbGpPWpGaD
Rimexolone—Pruritus—Etoposide—hematologic cancer	2.11e-05	0.000636	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.11e-05	0.00177	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.11e-05	0.00177	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.1e-05	0.00176	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.08e-05	0.00174	CbGpPWpGaD
Rimexolone—Vision blurred—Methotrexate—hematologic cancer	2.07e-05	0.000621	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.06e-05	0.00172	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.05e-05	0.00172	CbGpPWpGaD
Rimexolone—Prednisone—NR3C1—hematologic cancer	2.03e-05	0.0184	CrCbGaD
Rimexolone—Dysgeusia—Epirubicin—hematologic cancer	2.01e-05	0.000604	CcSEcCtD
Rimexolone—Fluticasone Propionate—NR3C1—hematologic cancer	2e-05	0.0181	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	1.99e-05	0.00167	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	1.99e-05	0.00167	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—EP300—hematologic cancer	1.99e-05	0.00167	CbGpPWpGaD
Rimexolone—Vision blurred—Epirubicin—hematologic cancer	1.93e-05	0.000582	CcSEcCtD
Rimexolone—Pruritus—Triamcinolone—hematologic cancer	1.92e-05	0.000577	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—FAS—hematologic cancer	1.91e-05	0.0016	CbGpPWpGaD
Rimexolone—Prednisolone—NR3C1—hematologic cancer	1.87e-05	0.0169	CrCbGaD
Rimexolone—Headache—Etoposide—hematologic cancer	1.87e-05	0.000563	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	1.87e-05	0.00157	CbGpPWpGaD
Rimexolone—Dysgeusia—Doxorubicin—hematologic cancer	1.86e-05	0.000559	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	1.85e-05	0.00155	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	1.85e-05	0.00155	CbGpPWpGaD
Rimexolone—Headache—Prednisolone—hematologic cancer	1.84e-05	0.000555	CcSEcCtD
Rimexolone—Discomfort—Methotrexate—hematologic cancer	1.84e-05	0.000555	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	1.84e-05	0.00154	CbGpPWpGaD
Rimexolone—Betamethasone—NR3C1—hematologic cancer	1.83e-05	0.0166	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	1.83e-05	0.00153	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—CASC3—hematologic cancer	1.83e-05	0.00153	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	1.81e-05	0.00152	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	1.8e-05	0.00151	CbGpPWpGaD
Rimexolone—Vision blurred—Doxorubicin—hematologic cancer	1.79e-05	0.000538	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	1.78e-05	0.00149	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	1.78e-05	0.00149	CbGpPWpGaD
Rimexolone—Pruritus—Dexamethasone—hematologic cancer	1.74e-05	0.000523	CcSEcCtD
Rimexolone—Pruritus—Betamethasone—hematologic cancer	1.74e-05	0.000523	CcSEcCtD
Rimexolone—Discomfort—Epirubicin—hematologic cancer	1.72e-05	0.000519	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.72e-05	0.00144	CbGpPWpGaD
Rimexolone—Headache—Triamcinolone—hematologic cancer	1.7e-05	0.000511	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.67e-05	0.0014	CbGpPWpGaD
Rimexolone—Oedema—Epirubicin—hematologic cancer	1.67e-05	0.000504	CcSEcCtD
Rimexolone—Hypotension—Methotrexate—hematologic cancer	1.67e-05	0.000503	CcSEcCtD
Rimexolone—Hydrocortisone—ABCG2—hematologic cancer	1.66e-05	0.015	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.64e-05	0.00138	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.61e-05	0.00135	CbGpPWpGaD
Rimexolone—Discomfort—Doxorubicin—hematologic cancer	1.6e-05	0.00048	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.58e-05	0.00133	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.57e-05	0.00131	CbGpPWpGaD
Rimexolone—Hypotension—Epirubicin—hematologic cancer	1.56e-05	0.000471	CcSEcCtD
Rimexolone—Oedema—Doxorubicin—hematologic cancer	1.55e-05	0.000466	CcSEcCtD
Rimexolone—Headache—Betamethasone—hematologic cancer	1.54e-05	0.000463	CcSEcCtD
Rimexolone—Headache—Dexamethasone—hematologic cancer	1.54e-05	0.000463	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.53e-05	0.00129	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.52e-05	0.00127	CbGpPWpGaD
Rimexolone—Pruritus—Prednisone—hematologic cancer	1.51e-05	0.000456	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.51e-05	0.00126	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.48e-05	0.00124	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—RB1—hematologic cancer	1.46e-05	0.00123	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.46e-05	0.00122	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.46e-05	0.00122	CbGpPWpGaD
Rimexolone—Hypotension—Doxorubicin—hematologic cancer	1.45e-05	0.000435	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.45e-05	0.00121	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.44e-05	0.0012	CbGpPWpGaD
Rimexolone—Hydrocortisone—NR3C1—hematologic cancer	1.43e-05	0.013	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.43e-05	0.0012	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.43e-05	0.0012	CbGpPWpGaD
Rimexolone—Headache—Prednisone—hematologic cancer	1.34e-05	0.000403	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.3e-05	0.00109	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.3e-05	0.00109	CbGpPWpGaD
Rimexolone—Methylprednisolone—ABCB1—hematologic cancer	1.28e-05	0.0116	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.27e-05	0.00107	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.27e-05	0.00107	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.27e-05	0.00106	CbGpPWpGaD
Rimexolone—Pruritus—Methotrexate—hematologic cancer	1.27e-05	0.000381	CcSEcCtD
Rimexolone—Dexamethasone—ABCG2—hematologic cancer	1.24e-05	0.0112	CrCbGaD
Rimexolone—Pruritus—Epirubicin—hematologic cancer	1.18e-05	0.000356	CcSEcCtD
Rimexolone—NR3C1—Gene Expression—RARS—hematologic cancer	1.18e-05	0.000987	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.17e-05	0.000984	CbGpPWpGaD
Rimexolone—Headache—Methotrexate—hematologic cancer	1.12e-05	0.000337	CcSEcCtD
Rimexolone—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.11e-05	0.000928	CbGpPWpGaD
Rimexolone—Pruritus—Doxorubicin—hematologic cancer	1.1e-05	0.00033	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.07e-05	0.000901	CbGpPWpGaD
Rimexolone—Dexamethasone—NR3C1—hematologic cancer	1.07e-05	0.00965	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.06e-05	0.000893	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.05e-05	0.000881	CbGpPWpGaD
Rimexolone—Headache—Epirubicin—hematologic cancer	1.05e-05	0.000316	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.03e-05	0.000867	CbGpPWpGaD
Rimexolone—Prednisone—ALB—hematologic cancer	1.03e-05	0.00929	CrCbGaD
Rimexolone—Prednisone—ABCB1—hematologic cancer	9.8e-06	0.00886	CrCbGaD
Rimexolone—Headache—Doxorubicin—hematologic cancer	9.7e-06	0.000292	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	9.67e-06	0.00081	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	9.64e-06	0.000808	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RARA—hematologic cancer	9.6e-06	0.000805	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—TET2—hematologic cancer	9.6e-06	0.000805	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	9.47e-06	0.000794	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPLP1—hematologic cancer	9.42e-06	0.000789	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—STAT3—hematologic cancer	9.38e-06	0.000786	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	9.37e-06	0.000785	CbGpPWpGaD
Rimexolone—Prednisolone—ABCB1—hematologic cancer	9.03e-06	0.00817	CrCbGaD
Rimexolone—NR3C1—Gene Expression—NR0B2—hematologic cancer	8.93e-06	0.000748	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	8.91e-06	0.000747	CbGpPWpGaD
Rimexolone—Betamethasone—ABCB1—hematologic cancer	8.85e-06	0.00801	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	8.82e-06	0.000739	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	8.74e-06	0.000732	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—TGFB1—hematologic cancer	8.69e-06	0.000729	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	8.64e-06	0.000724	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT3A—hematologic cancer	8.52e-06	0.000714	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ELL—hematologic cancer	8.39e-06	0.000703	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	8.21e-06	0.000688	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	8.18e-06	0.000686	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—TNF—hematologic cancer	8.12e-06	0.00068	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOR2—hematologic cancer	8.06e-06	0.000675	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	7.79e-06	0.000653	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AGO2—hematologic cancer	7.43e-06	0.000623	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	7.28e-06	0.00061	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—H3F3B—hematologic cancer	7.28e-06	0.00061	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	7.01e-06	0.000588	CbGpPWpGaD
Rimexolone—Hydrocortisone—ABCB1—hematologic cancer	6.91e-06	0.00625	CrCbGaD
Rimexolone—NR3C1—Gene Expression—RPS14—hematologic cancer	6.66e-06	0.000558	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NUP98—hematologic cancer	6.55e-06	0.000549	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—IL6—hematologic cancer	6.55e-06	0.000549	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NUP214—hematologic cancer	6.32e-06	0.000529	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	6.12e-06	0.000513	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	5.91e-06	0.000496	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	5.82e-06	0.000488	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HSPB1—hematologic cancer	5.82e-06	0.000488	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.66e-06	0.000474	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SMC1A—hematologic cancer	5.57e-06	0.000467	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—H3F3A—hematologic cancer	5.46e-06	0.000458	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	5.36e-06	0.000449	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EZH2—hematologic cancer	5.24e-06	0.000439	CbGpPWpGaD
Rimexolone—Dexamethasone—ABCB1—hematologic cancer	5.15e-06	0.00466	CrCbGaD
Rimexolone—NR3C1—Gene Expression—PARP1—hematologic cancer	5.13e-06	0.00043	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HDAC2—hematologic cancer	4.95e-06	0.000415	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AR—hematologic cancer	4.29e-06	0.000359	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.95e-06	0.000331	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.75e-06	0.000314	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.18e-06	0.000267	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MAPK14—hematologic cancer	3e-06	0.000252	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ESR1—hematologic cancer	2.94e-06	0.000247	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.85e-06	0.000239	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.58e-06	0.000216	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.57e-06	0.000132	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MYC—hematologic cancer	1.53e-06	0.000128	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.06e-06	8.9e-05	CbGpPWpGaD
